Combining Lovastatin and a Parent-Implemented Language Intervention for Fragile X Syndrome

NCT02642653 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Fragile X Syndrome
Genetic Diseases

Interventions

DRUG: Lovastatin
OTHER: Placebo

Sponsor

University of California, Davis